- Telehealth Visits
- Insurance plan information
Max Brondfield, MD
Gastroenterology- Telehealth Visits
- Insurance plan information
Max Brondfield, MD
Gastroenterology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Gastroenterology, American Board of Internal Med/Gastroenterology
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Gastroenterology, University of CA at San Francisco School of Med
Residency
- University of California San Francisco - GME
Internship
- Internal Medicine, University of CA at San Francisco School of Med
Degree
- MD, UCSF School of Medicine
Academic title
- Health Sciences Clinical Professor
My expertise
Specialties
Locations
My research
Clinical trials
Fecal Microbiota Transplant National RegistryOpens in a new window
Recruiting
Adverse events to be monitored include surgeries, infection, hospitalization, other life-threatening events, death and newly diagnosed diseases.
Publications
Showing 1-6 of 55 reviews
- May 23, 20265 out of 5 Stars
Dr Brondfield is fantastic and I also appreciated Grace, the fellow who joined.
- May 13, 20265 out of 5 Stars
LOVE Dr. B and his resident was fantastic. They're both excellent listeners.
- April 30, 20264.9 out of 5 Stars
Both Dr'a are fantastic in relating info and explaining their views. Brilliant, caring doctor!
- April 7, 20264.9 out of 5 Stars
Doctor and assistant doctor knowledgeable, good listeners and helpful in moving forward with a treatment plan.
- March 26, 20265 out of 5 Stars
Very good experience with initial contact and second contact with Doctor.
- March 5, 20265 out of 5 Stars
He is the BEST!
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.